Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early,…
Browsing: Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder that is the most common cause of dementia, affecting memory, thinking, and behavior. It typically begins with mild memory loss and gradually worsens, eventually interfering with daily tasks and cognitive function. Characterized by the buildup of abnormal protein deposits—amyloid plaques and tau tangles—in the brain, Alzheimer’s is currently incurable, though research is rapidly evolving. Ongoing scientific studies are exploring its causes, early detection methods, genetic risk factors, and potential treatments, with the goal of better understanding and ultimately halting or reversing the disease.
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from…
The interaction between the brain and the vascular system could hold the key to lowering…
OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for…
Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it…
According to the authors, the research opens up new possibilities for developing the next generation…
The study included 44 individuals with mild cognitive impairment. After six months, those who engaged…
The new test could help identify which patients are most likely to benefit from new…
Lowering your “bad” cholesterol might be doing more than just protecting your heart, it could…
Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have identified the precise…
A new study from Auburn University provides new insights into neuronal connections, offering hope for…
Cells don’t just follow a rigid script when responding to stress – they’re far more…
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that removing…
The brain’s immune cells removed plaques and helped restore a healthier environment in the brains…
Type 2 diabetes may quietly alter the brain in ways that mimic early Alzheimer’s, weakening…
McGill researchers found lecanemab may be less effective in women, prompting calls for more personalized…
Aging brains may struggle to clear out waste, contributing to memory loss and diseases like…
New research warns that blood tests for Alzheimer’s disease may be unreliable, particularly for Black…